Indications and Contraindications for TIPS
Primary Indications
TIPS is strongly recommended for three main indications in cirrhotic patients: refractory ascites, acute variceal hemorrhage (particularly as preemptive TIPS in high-risk patients), and hepatic hydrothorax requiring recurrent thoracentesis 1, 2.
Variceal Bleeding
- Preemptive TIPS should be placed in patients with acute variceal bleeding who are at high risk for treatment failure (typically Child-Pugh B with active bleeding or Child-Pugh C <14 points) after successful initial endoscopic control 2, 3
- This approach achieves hemorrhage control in 90-100% of cases and significantly improves survival compared to standard therapy 3, 4
- Despite strong evidence, less than 20% of eligible patients currently receive preemptive TIPS 3
Refractory Ascites
- TIPS is superior to serial large volume paracentesis (LVP) for both ascites control and transplant-free survival in carefully selected patients 2
- Consider TIPS even in patients not meeting strict refractory criteria if they require ≥3 large volume paracenteses yearly despite optimal medical therapy 2
- Use ePTFE-covered controlled expansion stents with staged dilation: start at 8mm, then progressively dilate to 9mm and 10mm at 6-week intervals based on clinical response 2
- Expected timeline for effectiveness: reassess every 6 weeks while maintaining diuretics as tolerated 2
Hepatic Hydrothorax
- TIPS should be considered for patients requiring recurrent thoracentesis 2
- Patient selection criteria are similar to those for refractory ascites 2
Absolute Contraindications
The following are absolute contraindications to TIPS placement 3:
- Severe uncontrolled hepatic encephalopathy
- Systemic infection or sepsis
- Congestive heart failure
- Severe pulmonary arterial hypertension
- Biliary obstruction
Relative Contraindications and Risk Factors
Liver Dysfunction Thresholds
While elevated bilirubin, elevated MELD score, and Child-Pugh class C cirrhosis are associated with increased post-TIPS complications and mortality, there is insufficient evidence to recommend absolute cutoffs 2. However, most centers consider bilirubin >5 mg/dL as a relative contraindication 5.
Age Considerations
Advanced age is significantly associated with severe hepatic encephalopathy and death post-TIPS, but no specific age cutoff should be considered an absolute contraindication 2. Clinical judgment based on overall functional status is more important than chronological age alone.
Cardiac and Renal Function
Assessment of cardiac and renal function prior to TIPS is essential to improve patient prognosis 4. Right heart catheterization should be considered in patients with suspected cardiac dysfunction.
Pre-Procedure Requirements
A hepatogastroenterologist must be involved in the initial decision for elective TIPS, with subsequent consultation by a competent proceduralist 1. If center expertise is unavailable, referral to an expert center is mandatory 1.
Additional specialty consultations (transplant surgery, cardiology, nephrology, neurology) should be considered case-by-case 1.
Common Pitfalls to Avoid
- Underutilization of preemptive TIPS: Despite Level 1 evidence, most eligible high-risk variceal bleeding patients are not offered this life-saving intervention 3
- Inappropriate patient selection: Failure to assess cardiac function, hepatic encephalopathy risk, and liver dysfunction severity leads to poor outcomes
- Inadequate staged approach for ascites: Starting with oversized stents increases complications; always begin at 8mm and titrate upward 2
- Ignoring multidisciplinary evaluation: TIPS decisions require input from hepatology and interventional radiology at minimum 1
Special Populations
Post-liver transplant patients with refractory ascites: There is insufficient evidence to support TIPS or recommend it over alternative therapies in this population 2.